Margit Kunz – Chief Executive Director, AHK Debelux
Germany and Belgium have long held an important trading relationship, says Margit Kunz of AHK Debelux, the German chamber of commerce in Belgium and Luxembourg. She outlines some of the…
Address: Namur Office Park | Avenue des Dessus de Lives, 6 | B-5101 Loyers (Namur)
Tel: +32 81 33 28 50
Web: http://www.investinwallonia.be/?lang=en
Helping foreign investors to successfully set up and integrate their activities as part of the regional economic fabric.
The Foreign Investors division of the Agence Wallonne à l’Exportation et aux Investments étrangers (AWEX) (Walloon Exports and Foreign Investments Agency) is home to a multilingual team of expert consultants who are entirely at your service.
From an initial feasibility study all the way up to signing on the dotted line in concluding the investment, we provide personalised assistance geared to your needs and situation.
If you are a foreign investor looking to develop your activities in Wallonia, you can rest safe in the knowledge that our team of experts is there to assist you every step of the way.
Contact us!
Investor services : the point of single contact for all aspiring foreign investors seeking to set up business in Wallonia.
Our remit is:
to help you in seeking out appropriate sites and premises;to provide assistance with the start-up, development and diversification of your business;
to help you gain access to venture capital;
to provide advice and assistance in attracting suitable human resources;
to help you with setting up training programmes;
to provide assistance in obtaining subsidies from the Regional and European authorities;
to provide legal, tax and logistics support;
Germany and Belgium have long held an important trading relationship, says Margit Kunz of AHK Debelux, the German chamber of commerce in Belgium and Luxembourg. She outlines some of the…
Perhaps to the surprise of many, Belgium is the world’s second-largest producer of vaccines, behind only the US, and – capitalising on its years of experience in the field –…
Back home in Belgium after a stellar stint in Big Pharma, Dr Paul Stoffels is now looking to reshape the future of cancer care with the previously struggling biotech he…
Belgian healthcare performs strongly across most metrics and international comparisons, but – as elsewhere – there remains room for improvement in terms of integrating patient feedback and experience into the…
20-year Astellas veteran Mark Dekker – now back in his home country of the Netherlands and overseeing the Benelux cluster having primarily developed his career in emerging European markets –…
Marnix Denys of beMedTech – the Belgian association for the medical technology industry – outlines the agenda priorities for the organisation that he hopes will lead to a more value-driven…
RaDiOrg aims to support rare disease patients and patient organisations in Belgium, defend their interests, and raise awareness of what can be devastating and little-understood conditions. Director Eva Schoeters –…
The newly merged Port of Antwerp-Bruges is the world’s first GDP-compliant seaport. CCO Tom Hautekiet explains the significant role the Port is playing in global healthcare supply chains – leveraging…
Back home in Belgium after a stellar stint in Big Pharma, Dr Paul Stoffels* is now looking to reshape the future of cancer care with the biotech he helped co-found…
Univercells is a group of companies founded a decade ago based around the concept of revolutionizing the availability of biologics around the world through making essential medicines affordable to all,…
GSK has undergone a number of changes in recent years. After driving a major transformation that began in 2017 to strengthen its R&D performance, the British multinational suffered the impact…
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has elected a new president and vice presidents who have set out a key priority for their term: a series of…
See our Cookie Privacy Policy Here
